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Abstract
Benzene is a ubiquitous environmental contaminant and is widely used in industry. Exposure to benzene causes a number
of serious health problems, including blood disorders and leukemia. Benzene undergoes complex metabolism in humans,
making mechanistic determination of benzene toxicity difficult. We used a functional genomics approach to identify the
genes that modulate the cellular toxicity of three of the phenolic metabolites of benzene, hydroquinone (HQ), catechol
(CAT) and 1,2,4-benzenetriol (BT), in the model eukaryote Saccharomyces cerevisiae. Benzene metabolites generate oxidative
and cytoskeletal stress, and tolerance requires correct regulation of iron homeostasis and the vacuolar ATPase. We have
identified a conserved bZIP transcription factor, Yap3p, as important for a HQ-specific response pathway, as well as two
genes that encode putative NAD(P)H:quinone oxidoreductases, PST2 and YCP4. Many of the yeast genes identified have
human orthologs that may modulate human benzene toxicity in a similar manner and could play a role in benzene
exposure-related disease.
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Introduction
Benzene is a ubiquitous chemical in the environment, and is
used in industry for the production of several important chemicals
required for the synthesis of products that include plastics, resins,
dyes and detergents. Benzene is also present in gasoline and
cigarette smoke, resulting in extensive global population, as well as
occupational, exposure. In the developing world, benzene is used
as an industrial solvent, which leads to severe occupational
exposures. The adverse health effects of benzene exposure were
first described over one hundred years ago and it is now
recognized as a cause of human blood disorders (hematotoxicity)
and leukemia (reviewed in [1]).
Benzene undergoes extensive and complex metabolism in the
human body, resulting in a number of well-characterized reactive
metabolites [2]. This metabolism has made the elucidation of the
mechanism of benzene carcinogenicity difficult, and it is
speculated that a number of these metabolites work in concert
to cause leukemia and other disorders [3,4]. One class of benzene
metabolites implicated as causative agents of benzene-associated
disease, are the phenolic compounds hydroquinone (HQ), catechol
(CAT), and 1,2,4-benzenetriol (BT). These compounds are all
formed by the hydroxylation of phenol, which can be derived
through a nonenzymatic rearrangement of benzene oxide, which
is itself formed by the action of Cytochrome P450s on benzene in
the liver and perhaps other organs [2]. HQ, CAT and BT can
travel to the bone marrow and are oxidized both through
autoxidation and by myeloperoxidase (MPO) to highly toxic
quinones [4]. In humans, NAD(P)H:quinone oxidoreductase 1
(NQO1) catalyses the two-electron reduction of these quinones,
detoxifying them to a less toxic hydroquinone. A polymorphism of
NQO1, NQO1*2, has been linked to benzene toxicity and
hematopoietic disorders [5]. NQO1*2 has a much shorter half-life
than NQO1, leading to the suggestion that efficient reduction of
the quinones produced from HQ, CAT and BT is an important
defense against benzene toxicity. Indeed, other single-nucleotide
polymorphisms (SNPs) in both NQO1 and MPO have been shown
to influence susceptibility to benzene hematotoxicity in individuals
with low level occupational exposure [6]. Therefore, HQ, CAT,
and BT may contribute significantly to benzene toxicity in the
context of occupational exposure.
The phenolic metabolites of benzene, and especially their
respective derived quinones, are highly reactive and known to
non-specifically bind both DNA and protein, as well as to induce
oxidative stress [7,8,9,10]. This reactivity may in part explain the
non-classical carcinogenesis of benzene. So-called classical carcin-
ogens, such as benzo(a)pyrene, covalently bind DNA and are
highly mutagenic, as measured by the Ames reversion test [11].
Although there is evidence that benzene and its metabolites can
cause damage to DNA [12,13], the levels detected are lower than
those seen with known DNA-damaging carcinogens and benzene
is an Ames negative compound [14]. Although the molecular
modes of action of the phenolic metabolites of benzene in disease
remain unclear, it has been postulated that they could produce
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spindle, inhibition of topoisomerase II and the formation of DNA
strand breaks via reactive oxygen species (ROS) production [1,15].
Additional characterization of the modes of action of these
compounds is important to further our understanding of the
pathology and susceptibility to benzene-associated disease.
The ascomycete yeast Saccharomyces cerevisiae is an ideal model
organism for assessing gene function in mediating toxicity in
response to environmental toxicants. Firstly, yeast shares many
fundamental cellular processes with humans, which are extremely
well characterized. Secondly, the functional tools available,
particularly the genome-wide deletion strain collections, allow
easy interrogation of the phenotype of every knockout under
selective conditions [16]. Previous studies have revealed a low
correlation between the upregulation of a specific gene’s
transcription and its requirement for growth under selective
conditions [16,17], and so growth studies are considered to be a
more robust assay to identify genes required for the response to
toxicant treatment. This approach has been used to gain insight
into the genetic requirements for response to several compounds
and nutritional states [16,18,19,20,21], and the human homologs
or functional orthologs of genes identified by this approach have
been implicated in altered sensitivity to the same compounds in
human cells [22].
Here we report the findings of a genome-wide functional
profiling screen of yeast to determine the genes required for
optimal growth in response to treatment with HQ, CAT and BT.
Our results indicate that a primary mode of toxicity of the
phenolic metabolites of benzene is through the generation of
oxidative stress. We also identified a requirement for the vacuolar
ATPase and the correct regulation of iron homeostasis. Many of
the yeast genes identified have human orthologs that could
potentially modulate toxicity in a similar manner.
Results
Functional profiling of the yeast genome in response to
hydroquinone, catechol and 1,2,4-benzenetriol reveals a
dose- and time-dependent increase in differentially
sensitive strains
The three phenolic benzene metabolites tested, hydroquinone
(HQ), catechol (CAT), and 1,2,4-benzenetriol (BT), showed varying
potencies of growth inhibition of the wild type yeast strain (Figures
S1, S2 and S3); BT is the most inhibitory while HQ is the least. In
order to study and compare the genetic requirements of yeast for
growth in the presence of these compounds, we selected equitoxic
concentrations that resulted in 20% growth inhibition of the wild
type (IC20), as well as 50% and 25% of this IC20 (Table 1). We
exposed pools of yeast homozygous diploid deletion mutants
(n=4607) for 5 generations and 15 generations of growth (5 g
and15 g), totalingsix treatmentsperbenzene metabolite,with three
biological replicates of each (Table 1).
We used a differential strain sensitivity analysis (DSSA, described
in Methods) to identify genes required by yeast for toleranceto these
compounds. The number of identified strains (genes) correlated
directly both to the dose and the number of generations of growth
(Figure 1, Tables S1, S2 and S3), and show differing degrees of
overlap (Figure 2). In total, 163 deletion strains were identified by
DSSA as significantly sensitive to treatment with HQ (Table S1). Of
these, 31 were significantly sensitive in three or more of the six
treatment conditions (Table 2). 238 deletion strains were identified
as sensitive to treatment with CAT (Table S2), with 33 in three or
more treatment conditions (Table 3), and 122 as sensitive to BT
(Table S3), with 12 sensitive in 3 or more conditions (Table 4).
Functional category enrichment analysis indicates
common requirements for tolerance of benzene
metabolites
We analyzed the sensitive data sets for each metabolite (i.e.
those with negative fitness scores from DSSA) for enrichment of
biological attributes by identifying significantly overrepresented
MIPS (Munich Information Center for Protein Sequences)
Functional Classification categories (Table 5). A number of
functional categories were shared by more than one metabolite
including the oxidative stress response (MIPS Category 32.01.01)
and the vacuole (42.25).
Pathway enrichment, hierarchical clustering and network
clustering analyses reveal shared tolerance requirements
We performed two pathway analyses of the microarray data
(described in Methods). In the first, we identified significantly
enriched KEGG (Kyoto Encyclopedia of Genes and Genomes)
pathways required for tolerance to treatment within the 5 g and
15 g data sets for each benzene metabolite (Table S4). Of the 99
annotated KEGG pathways available for S. cerevisiae, 43 had at least
60% of their genes represented in the data sets. These 43 were then
clustered to determine shared tolerance pathways in both a
compound- and generational-dependent context (Figure 3A). In
the second analysis, we mapped data for all metabolites to the
STRING database of S. cerevisiae protein-protein interactions and
identified clusters(sub-networks)enrichedfortargetsofany benzene
metabolite (Figure 3B-E). Sub-networks from this analysis were then
assessed for significant overrepresentation of Gene Ontology (GO)
Biological Process categories. 19 sub-networks were identified at 5 g
(Table S5), and 41 at 15 g (Table S6).
These analyses identified components required for response to
all three metabolites and complement the DSSA and MIPS
Table 1. Benzene metabolite treatments used in functional profiling experiments.
Hydroquinone Catechol 1,2,4-Benzenetriol
Growth inhibitory
concentration 5 g 15 g 5 g 15 g 5 g 15 g
25% IC20 1 mM 1 mM 0.55 mM 0.55 mM 87.5 mM8 7 . 5 mM
50% IC20 2 mM 2 mM 1.1 mM 1.1 mM 175 mM1 7 5 mM
IC20 4 mM 4 mM 2.2 mM 2.2 mM 350 mM3 5 0 mM
Each treatment was performed in triplicate for a total of 18 pools of homozygous mutants per metabolite and compared with 12 rich media (YPD) controls in order to
identify the strains that exhibit a significant change in growth.
doi:10.1371/journal.pone.0024205.t001
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pathway approaches would also allow the identification of essential
genes likely to be involved in the processes overlooked in our study
due to our lack of essential gene representation.
Benzene metabolites induce oxidative stress
We found that multiple cellular components involved in the
response to and protection from oxidative stress are required for
growth in the presence of the three benzene metabolites. HQ,
CAT and BT can all autoxidize to form quinones (HQ to 1,4-
benzoquinone (1,4-BQ), CAT to 1,2-benzoquinone (1,2-BQ) and
BT to 2-hydroxy-1,4-benzoquinone (2-OH-1,4-BQ)), and thus can
undergo redox cycling by interacting with single electron acceptors
such as O2, leading to the accumulation of reactive oxygen species
(ROS) [23]. Phenolic compounds such as HQ, CAT and BT can
also produce hydroxyl radicals through reaction with iron [24],
and redox cycling. The oxidative stress response (32.01.01) was the
most significantly overrepresented MIPS category in the HQ and
BT data (Table 5), and the identification of oxygen and radical
detoxification (32.07.07) in the CAT data indicates that all three
compounds cause oxidative stress. A requirement for the oxidative
stress response was not identified by pathway analysis as it is not a
KEGG pathway and has few protein-protein interactions due to it
being a transcriptional response.
Yap1p and Skn7p are transcription factors that control two
specialized oxidative stress regulons in yeast [25]. Both yap1D (BT-
hereafter, the benzene metabolite treatments in which each strain
was identified are indicated in parentheses following gene names)
and skn7D (HQ, CAT, BT) were identified as being significantly
sensitive to treatment with benzene metabolites, and subsequent
analysis of the strains individually confirmed sensitivity (Figure 4A).
Previous studies show that yap1D and skn7D both exhibit decreased
resistance to oxidative stress, in part due to decreased induction of
antioxidant defense pathways [25]. The strains were both least
sensitive to CAT and most sensitive to BT. Several members of the
Yap1p signal transduction pathway were also identified as
sensitive: HYR1 (HQ, BT) encodes a thiol peroxidase that senses
intracellular hydroperoxide levels and transduces a redox signal to
Yap1p [26,27], while YBP1 (BT) is required for the oxidation of
cysteine residues of Yap1p [28]. In the absence of Ybp1p there is
no nuclear accumulation of Yap1p in response to stress.
To provide further evidence of oxidative stress induction, we
assessed the fitness of a strain overexpressing YAP1 when exposed
to HQ, CAT and BT (Figure 4B). YAP1 overexpression has
previously been shown to increase resistance to several oxidative
stress-inducing compounds [29,30,31], and we found that it
increased resistance of yeast cells to treatment with HQ and CAT
(Figure 4B). The decrease in HQ and CAT toxicity observed
following increased induction of antioxidant response genes
suggests that both metabolites result in increased ROS. YAP1
overexpression did not result in increased growth over WT
following BT treatment (Figure 4B) even though BT appears to be
the strongest oxidative stressor of the three (since yap1D was most
sensitive to BT). We hypothesize that Yap1p may be saturated in
WT cells following BT treatment i.e. that the downstream
response is already maximal. The relatively small increase in
tolerance to HQ and CAT can be explained by the observation
that YAP1 is only slightly overexpressed in this strain [32]. The
Figure 1. Numbers of sensitive and resistant deletion strains identified by differential sensitivity analysis (DSSA). Exposures were
comprised of three equitoxic concentrations of HQ, CAT and BT, equivalent to 25% IC20, 50% IC20, and the IC20 for 5 g and 15 g of growth, resulting in
a total of six treatments per benzene metabolite. The number of significant strains increased as the dose and number of generations increased.
doi:10.1371/journal.pone.0024205.g001
Functional Profiling of Benzene Toxicity
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e24205commercially available SKN7 overexpression strain was not
assessed as Skn7p levels do not change [32] (the strain also has
severe growth defects).
Yap3p – hydroquinone-specific nuclear localization and
sensitivity
The eight-member Yap family of basic leucine zipper (bZIP)
transcription factors responds to cellular stressors [33]. In addition
to the Yap1p oxidative stress response, Arr1p (Yap8p) responds to
arsenicals [34], while Cad1p (Yap2p) responds to cadmium [31].
DSSA showed yap3D to be sensitive to HQ, which was confirmed
by follow-up analysis (Figure 4C). Interestingly, yap3D was not
found to be sensitive to CAT or BT (Figure 4C), indicating that
Yap3p could be part of a specific stress response to HQ; the Yap3p
response pathway has not been previously characterized. To
further investigate the role of Yap3p, we determined the cellular
localization of Yap3p following HQ, CAT and BT stress. As a
control we studied Yap1p, which is retained in the nucleus
following treatment with the oxidative stressor hydrogen peroxide
[35]. We assessed the cellular distribution of Yap3-GFP and Yap1-
GFP following 30 minutes treatment with the IC20 doses of HQ,
CAT and BT. yap1D is sensitive to HQ, CAT and BT and we
found Yap1-GFP was retained in nuclei following treatment with
all three metabolites. In contrast, Yap3-GFP was retained only
following treatment with HQ (Figure 4D), supporting a specific
role for Yap3p in the transcriptional response to HQ.
To further assess the functional role of Yap3p in cellular
tolerance of HQ, we assessed the fitness of a strain overexpressing
YAP3. Unlike YAP1 overexpression, YAP3 overexpression did not
result in increased tolerance to HQ, CAT or BT treatment
(Figure 4E). The strain tested only overexpresses YAP3 at a low
level [32], thus it is possible that no resistance to HQ was seen due
to the only minor increase in protein abundance. It could also be
due to a combination of a small number of transcriptional targets
coupled with already maximal induction of the Yap3p pathway in
response to HQ treatment in WT cells.
Oxidative stress protection is required for benzene
metabolite tolerance
The thioredoxin and the glutaredoxin pathways carry out a
significant amount of cellular oxidative stress protection. Several
members of the cytoplasmic thioredoxin system were required for
metabolite tolerance: Trx2p (HQ, CAT, BT), one of two yeast
thioredoxin isoenzymes and cofactor of Tsa1p (CAT, BT) a
thioredoxin peroxidase that acts as both a ribosome-associated and
free cytoplasmic antioxidant. Deletion of TSA1 results in
Figure 2. Venn diagrams showing the number of overlapping and distinct genes between treatments. A More genes were specific to
15 g with some overlap with 5 g. B Similarly, many genes at the highest HQ, CAT and BT concentrations were not found at the lower concentrations.
C HQ, CAT and BT treatments identified different and overlapping sets of genes.
doi:10.1371/journal.pone.0024205.g002
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sulfiredoxin, a protein that contributes to oxidative stress resistance
by reducing oxidant-formed cysteine-sulfinic acid groups in Tsa1p
[38]. Finally, Csr1p (HQ, CAT, BT), which specifically interacts
with thioredoxin peroxidase and may have a role in oxidative
stress resistance [39].
Although oxidative stress was observed (as measured by the
sensitivity of yap1D and the induction of the thioredoxin pathway),
we found little requirement for the glutathione (glutaredoxin)
pathway in yeast benezene metabolite tolerance, in contrast to
data from both rodent and human epidemiological studies
[15,40,41]. Given the contrasting data, we analyzed the growth
of gsh1D and glr1D, involved in GSH synthesis and recycling, in the
presence of HQ, CAT and BT (Figure S4). gsh1D showed no
sensitivity to HQ and mild sensitivity to CAT and BT, while glr1D
was not sensitive to CAT or BT, but was sensitive to HQ.
However, at the IC20 dose of each, there was no significant
requirement for GSH. Conversely, KEGG pathway analysis
identified glutathione metabolism (KEGG pathway map00480)
as significantly required for tolerance (Figure 3A). Together these
data suggest that glutathione plays a less significant role than
thioredoxin in yeast, and perhaps only responds to severe stress.
Benzene metabolites induce endoplasmic reticulum
stress
Deletion of proteasome transcription factor RPN4 (HQ, BT),
ubiquitin-conjugating enzyme UBC7 (HQ), or ubiquitin-protein
ligase HRD1 (HQ), results in significant sensitivity to HQ. hrd1D is
deficient in ER-associated protein degradation (ERAD) [42],
suggesting the presence of damaged proteins and endoplasmic
Table 2. Genes with significant negative log2 ratios from DSSA identified in at least three of the six HQ treatments.
ORF Standard name 5g 1 5g
25% IC20 50% IC20 IC20 25% IC20 50% IC20 IC20
1 mM 2 mM 4 mM 1 mM 2 mM 4 mM
YOL081W IRA2 22.5 23.3 24.1 24 26.2 22.6
YOL085C 21.95 22.1 23 24.35 24.85 23.3
YHL009C YAP3 22.3 22.3 22.9 24.15 23.6
YJL121C RPE1 22.2 22.4 22.85 23.3 23
YDR032C PST2 22.3 23 22.3 23.4 23.2
YOL013C HRD1 21.5 22.1 24.2 23.8 23.1
YOL079W 22.4 22.45 23.55 22.95 23.35
YOL025W LAG2 21.7 21.9 23.5 23.3 22.55
YJL120W 21.9 22.25 23.9 23.8
YGR130C 22.1 22.2 22.4
YLR077W FMP25 21.6 21.5 21.1
YKL147C 21.6 21.4 21.3
YCR068W ATG15 21.6 21.2 21.6
YMR237W BCH1 21.5 21.3 21.4
YOR084W LPX1 21.3 21.4 21.3
YCR004C YCP4 21.5 21.5 23.6
YOR325W 21.3 21.6 22.2
YDL020C RPN4 21.6 23.8 23.4
YNL148C ALF1 21.9 22.5 23.9
YGR139W 21.7 21.5 21.5
YHR030C SLT2 21.6 22.7 23.3
YKL040C NFU1 21.4 21.9 22.1
YIL162W SUC2 23.8 24.4 24.1
YMR022W UBC7 22.4 22.4 22.2
YBR035C PDX3 22.4 22.4 22.3
YPR074C TKL1 22.3 23.1 23.8
YDL225W SHS1 21.8 23.2 22.9
YDR112W IRC2 24.1 24.4 24.3
YEL056W HAT2 23.6 23.7 23.8
YDR457W TOM1 23.1 23.2 22.2
YPL138C SPP1 22.8 23.3 23.2
The requirement of a gene for optimal growth in HQ is quantified with a fitness score, defined as the normalized log2 ratio of the deletion strain’s growth. A total of 31
(19%) of the identified genes were important for fitness (i.e. had negative fitness scores) in at least three of the six HQ treatments. Most genes identified were significant
in one or two treatments and after 15 g of growth. See Table S1 for the list of all identified genes.
doi:10.1371/journal.pone.0024205.t002
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adducts [9]. Kinase SLT2 (HQ, CAT), involved in ER stress
response, is also required for tolerance [43]. HQ, CAT and BT all
reduce disulfide bridges by binding thiol groups in cysteines in the
same manner as the reducing agent dithiothreitol (DTT), which is
used experimentally to induce ER stress.
Membrane lipids are cellular targets of benzene
metabolites
Lipid/fatty acid transport (MIPS category 20.01.13) was
identified in both the CAT and BT DSSA analysis (Table 5),
and several pathways involved in lipid and fatty acid metabolism
were identified by KEGG analysis (Figure 3A). Lipid peroxidation,
the oxidative degradation of membrane lipids by free radical
species, is caused by benzene metabolites[8] but is expected to be a
secondary outcome of the oxidative stress that they cause;
sensitivity is likely due to defects in new lipid metabolism, required
to replace damaged membrane components. Genes identified
include: ISC1 (HQ), a mitochondrial phospholipase C that
hydrolyses complex sphingolipids to produce ceramide, a major
component lipid of cell membranes. ISC1 has functional orthologs
in both rats and humans, and de novo synthesis of ceramide is
significantly inhibited by high doses of benzene in rats [44]. NCR1
(CAT), a functional ortholog of the human Niemann Pick C1
Table 3. Genes with significant negative log2 ratios from DSSA identified in at least three of the six CAT treatments.
ORF Standard name 5g 1 5g
25% IC20 50% IC20 IC20 25% IC20 50% IC20 IC20
0.55 mM 1.1 mM 2.2 mM 0.55 mM 1.1 mM 2.2 mM
YGR130C 22.3 22.2 22.3 21.9 21.8
YPR076W 21.8 21.8 21.7 22.9
YGR117C 22 22 21.9 23.1
YKR046C PET10 21.4 21.4 21.3 24
YDL211C 21.2 21.3 21.1 24
YAL002W VPS8 22.3 23.5 23.6 25
YJL120W 21.5 22.75 22.95 24
YKL133C 21.2 2.8 2.6 2.6
YJL121C RPE1 21.1 22.9 22.6 23.8
YOR084W LPX1 21.2 21.1 21.1
YPL230W USV1 21.2 21.2 21.1
YHR060W VMA22 21.4 22.05 22.45
YHR137W ARO9 22 22 21.9
YDL182W LYS20 21.7 21.9 21.8
YGL043W DST1 21.6 21.6 21.4
YGL071W AFT1 21.4 22.65 23.8
YKL119C VPH2 22 22.85 22.4
YOR089C VPS21 21.5 22.45 24.7
YCL007C 22.1 22.2 22.7
YOR331C 22.1 22.2 22.1
YKR052C MRS4 22.45 24.35 25.7
YMR153W NUP53 20.45 22.2 22
YFR036W CDC26 25.2 24.95 24.75
YKR020W VPS51 22.3 22.4 22.95
YKL071W 21.6 21.3 21.3
YKL123W 22.2 21.6 21.7
YKL222C 22.2 21.9 22
YGL094C PAN2 22.1 22.1 22.2
YGR110W CLD1 21.9 21.8 21.9
YDL236W PHO13 21.8 21.6 21.7
YKL051W SFK1 21.8 21.7 21.8
YKR033C 21.8 21.5 21.6
YHL026C 21.7 21.4 21.5
The requirement of a gene for optimal growth in CAT is quantified with a fitness score, defined as the normalized log2 ratio of the deletion strain’s growth. A total of 33
(14%) of the identified genes were important for fitness (i.e. had negative fitness scores) in at least three of the six CAT treatments. Most genes identified were
significant in one or two treatments and after 15 g of growth. See Table S2 for the list of all identified genes.
doi:10.1371/journal.pone.0024205.t003
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required for import of long chain fatty acids into peroxisomes;
the peroxisome (map04146) was also identified by KEGG pathway
analysis (Figure 3A) and could be required to prevent the fatty
acids accumulating in the cytosol, as occurs when its function is
impaired. Lastly, DRS2 (BT), a flippase that maintains vesicle
membrane lipid asymmetry, was identified; vesicle defects can
result in increased sensitivity through a number of routes including
reduced transport of damaged proteins to the vacuole.
The vacuole is important for benzene metabolite
tolerance
MIPS functional category analysis identified the vacuole/
lysosome (42.25) as important for response to CAT and BT. This
is supported by the identification of endocytosis by MIPS
(20.09.18.09.01) and KEGG pathway analysis (map04144-
Figure 3A) and by identification of the vacuole (Figure 3B),
endosomes (Figure 3C), and vacuolar ATPase (Figure 3D) by
protein-protein network analysis. Sensitive strains included vam7D
(CAT) and vam10D (CAT, BT) with defects in vacuolar morpho-
genesis, and vps3D (CAT) and vps8D (CAT) lacking proteins of the
CORVET endosomal tethering complex, required for biogenesis of
the vacuole and endosomes. Similarly, components of the V-
ATPasevacuolarproton pump (vma5D (HQ,BT),vma8D (CAT)and
cup5D (CAT)) and proteins required for correct assembly of the V-
ATPase (vph2D (CAT) and vma22D (HQ)) were identified as
significantly sensitive following treatment with each of the
metabolites tested. Sensitivity of vacuolar transport mutants could
be indicative of vesicle trafficking defects, supported by MIPS
analysis identification of protein targeting, sorting and translocation
(14.04), and vesicular transport (20.09.07, 42.09) and formation
(20.09.07.25) for CAT, and cellular export and secretion (20.09.16)
for BT (Table 5). Disruption of trafficking could be a secondary
effect of actin disruption by benzene metabolites (discussed below),
as endosomes move along actin [45]. Lipid peroxidation caused by
benzene metabolites could also lead to endosomal deficiency
through damage to vesicular membranes.
Iron homeostasis is required for benzene metabolite
tolerance
Several iron homeostasis-related deletion strains that are
sensitive to low iron were identified as sensitive to benzene
metabolite treatment by DSSA and growth analysis (Figure S5).
AFT1 (HQ, CAT, BT) and MAC1 (CAT, BT) encode transcription
factors required for the transcriptional response to low iron and
copper, respectively. aft1D cells are sensitive to low iron availability
[46], and mac1D exhibits a secondary iron deficiency due to
dependence of iron uptake on copper uptake, which is regulated
by Mac1p [47]. FRE8 (CAT, BT) encodes a protein with similarity
to iron/copper reductases, and the absence of Fre8p increases
sensitivity to low iron [47]. The requirement for V-ATPase
subunit Cup5p (CAT) connects the V-ATPase and iron homeo-
stasis, as it is important for both [48]. In contrast to higher
eukaryotes, yeast lacks ferritin as a means of storing iron and so the
majority of cellular iron is stored in the yeast vacuole. Disruption
of V-ATPase function causes an increase in vacuolar pH, resulting
in decreased iron solubility in the vacuole and decreased iron
availability to the cell [49,50]. The requirement of the V-ATPase
in benzene metabolite tolerance may be to ensure adequate
available iron. HQ and BT have been shown to chelate iron,
reducing bioavailability [51], and CAT releases iron from ferritin
by chelation [52].
NADPH is required for benzene metabolite tolerance
The pentose phosphate pathway (map00030) was identified by
KEGG analysis (Figure 3A), and two enzymes of this pathway
(Rpe1p and Tkl1p) were identified as sensitive to all three benzene
metabolites by DSSA, indicating a requirement for NADPH in
tolerance. The pentose phosphate pathway is required for the
efficient regeneration of cellular NADPH [53], which is needed for
a number of detoxification enzymes in yeast, including the
glutaredoxin and thioredoxin pathways. As YJL120W (HQ,
CAT, BT) is antisense to RPE1, deletion of this dubious ORF is
functionally equivalent to deletion of RPE1. Interestingly, KEGG
analysis showed a more significant requirement for the pentose
Table 4. Genes with significant negative log2 ratios from DSSA identified in at least three of the six BT treatments.
ORF Standard name 5g 1 5g
25% IC20 50% IC20 IC20 25% IC20 50% IC20 IC20
87.5 mM 175 mM 350 mM 87.5 mM 175 mM 350 mM
YBR292C 22.3 21.5 21.2 21.5
YJL120W 23.25 22.95 24.5 24.6
YGR130C 22.1 22.4 22.2
YJL121C RPE1 22.6 23.1 24.2
YHR206W SKN7 22.45 23.7 24.7
YML028W TSA1 22.2 22.7 23.3
YGL148W ARO2 21.3 22.6 23.05
YPR074C TKL1 21.3 23.75 23.9
YLR380W CSR1 21.1 24.6 22.8
YBR035C PDX3 22.2 22.4 22.6
YIL162W SUC2 22 23.3 23.7
YFR036W CDC26 23.1 24.3 24.4
The requirement of a gene for optimal growth in BT is quantified with a fitness score, defined as the normalized log2 ratio of the deletion strain’s growth. A total of 12
(10%) of the identified genes were important for fitness (i.e. had negative fitness scores) in at least three of the six BT treatments. Most genes identified were significant
in one or two treatments and after 15 g of growth. See Table S3 for the list of all identified genes.
doi:10.1371/journal.pone.0024205.t004
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requirement for NADPH regeneration is greater in earlier
generations. This may be due to rapid depletion of cellular
NADPH upon initial exposure that can be corrected over time by
upregulation of pathway genes.
The cytoskeleton is a cellular target of benzene
metabolites
Thesensitivityofalpha-tubulinfoldingproteinmutantalf1D(HQ,
CAT) suggests that microtubules may be cellular targets of benzene
metabolites. HQ can bind sulfhydyl groups and is known to inhibit
polymerization of microtubules in vitro [54,55], while BT has also
been shown to inhibit tubulin polymerization [56]. In yeast, HQ has
also been shown to induce aneuploidy, but not crossovers or gene
conversions [57], consistent with this hypothesis. Protein-protein
network analysis also identified the actin cytoskeleton as a cellular
component affected by benzene metabolite treatment (Figure 3E).
ARP1 (HQ) was identified and encodes an actin-related protein of
the dynactin complex, required for spindle orientation and nuclear
migration. This indicates that benzene metabolites induce cytoskel-
etal stress, and agrees with observations that deficiencies in HOG1
and SWE1 (kinases that signal cytoskeletal stress and induce cell
cycle arrest) abolish HQ-induced delay at the G2/M transition [57].
Actin stress could be a consequence of oxidative damage to cells by
benzene metabolites; hydrogen peroxide-induced oxidative stress is
known to cause actin reorganization in cultured human retinal
pigment epithelial cells [58] and HQ also produces actin aggregates
in the same cell type [59]. MIPS analysis provides additional
evidence of cytoskeletal stress, withthe identification of budding, cell
polarity and filament formation (43.01.03.05) and MAPKKK
Table 5. Genes required for growth in the presence of HQ, CAT and BT, and their associated MIPS Functional Categories (genes
were identified in at least one of the six treatments).
Hydroquinone
MIPS category p-value Genes identified k
a f
b
Oxidative stress response 0.0022 PST2, TRX2, SKN7, HYR1, OCA1, FRT1 65 5
Stress response 0.006581 CLN3, TPS2, SHO1, SLT2, CPR2, UTH1, UBC7, SIW14, RTS1, ASR1 10 162
Chemoperception and response 0.007785 RDS1, STB5, URE2 31 7
Budding, cell polarity and filament formation 0.009887 CLN3, RPN4, SHS1, SPT3, GIN4, SHO1, BUD27, SLT2, ARP1, RCY1,
HSL1, NAP1, TPM1, LPX1, BEM4
15 312
Catechol
MIPS category p-value Genes identified k
a f
b
Vacuolar/lysosomal transport 2.91E-12 VPS8, CCZ1, BSD2, STP22, PEP7, VPS3, CUP5, VMA8, VPS45, VAM7,
VPS35, ATG27, VPS25, VMA5, AVT3, YPT52, VPS51, SNF7, VPS36,
VPS9, PEP12, VPS21, VPS28, VPS30, ATG5, MRL1, VPS4
27 153
Protein targeting, sorting and translocation 6.48E-07 VPS8, CCZ1, BSD2, STP22, PEP7, VPS3, CUP5, VPS45, ERP5,
VTH1, PEP8, VPS35, VPS25, YPT52, VPS51, SSA2, SNF7, VPS36,
VPS9, NUP53, PEP12, VPS21, VPS17, TIM18, VPS28, VPS30, ATG5, VPS4
28 281
Vacuole or lysosome 2.39E-06 CCZ1, CUP5, VPS45, VAM7, TRX2, YHR138C, SFK1, VAM10, ATG5, VPS4 10 44
MAPKKK cascade 0.002368 PKH1, PTP3, SLT2, BCK1, SMK1 52 7
Vesicular transport 0.003929 TMN2, VPS45, VTH1, SSA2, YPT6, VPS9, VPS17, VPS30 87 2
Lipid/fatty acid transport 0.004421 DRS2, ITR1, SFH5, CSR1, PDR16, PDR5 64 4
Vesicle formation 0.004489 SYS1, ATG27, VPS51 31 0
Intracellular transport vesicles 0.004489 SYS1, ATG27, VPS51 31 0
Endocytosis 0.004768 FEN2, PKH1, CUP5, RCY1, YPT52, ENT4, VPS21 75 9
Homeostasis of protons 0.006153 CUP5, VMA8, VMA22, RAV1, VMA5, VPH2 64 7
Osmosensing and response 0.007552 PTP3, SHO1, VPS45, SLT2, YKL161C 53 5
Oxygen and radical detoxification 0.007806 PRX1, TRX2, TSA1 31 2
Electron transport 0.009263 GRX3, CUP5, VMA8, TRX2, OYE2, VMA5, SDH1, OYE3 88 3
1,2,4-Benzenetriol
MIPS category p-value Genes identified k
a f
b
Oxidative stress response 5.71E-05 YBP1, TRX2, SKN7, HYR1, SRX1, YAP1, TSA1 75 5
Vacuole or lysosome 0.001167 DOA4, TRX2, SFK1, VPS33, VAM10 54 4
Chemoperception and response 0.003383 RDS1, STB5, IZH2 31 7
Cellular export and secretion 0.00763 ERP3, GCS1, PHO86, FPS1 44 3
Lipid/fatty acid transport 0.008277 FPS1, CSR1, NCR1, PXA1 44 4
Homeostasis of metal ions 0.008941 SIT1, AFT1, VMA5, FRE8, MAC1, IZH2 69 8
aNumber of genes of specific category required for tolerance to benzene metabolite.
bNumber of genes of specific category by MIPS.
doi:10.1371/journal.pone.0024205.t005
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respectively (Table5).Disruption ofthe actin cytoskeleton could also
affect vesicle trafficking, as previously discussed.
Pst2p and Ycp4p – NAD(P)H:quinone oxidoreductases?
Both pst2D (HQ) and ycp4D (HQ) were identified by DSSA as
sensitive to only HQ. Pst2p and Ycp4p are members of a family of
three flavodoxin-like proteins (the third is Rfs1p), whose molecular
function and cellular role are unknown. Pst2p and Ycp4p have
both been detected in mitochondria in high-throughput studies,
but may also be present in the cytoplasm. Pst2p is 67% identical to
Ycp4p (100% coverage), and 53% identical to Rfs1p (98%
coverage). Ycp4p is the largest of the three proteins (247 amino
acids), and has a longer C-terminal region; Pst2p and Rfs1p are
similar in length (Pst2p is 198 amino acids; Rfs1p is 210 amino
acids). PST2 is induced by oxidative stress in a Yap1p-dependent
manner [25], and YCP4 has two upstream AP-1-like sites,
indicative of Yap1p-binding [60]. Sensitivity of both pst2D and
ycp4D to HQ was confirmed by analysis of the individual deletion
strains (Figure 5A). Neither mutant was sensitive to CAT, but both
were resistant to BT (Figure 5A). Domain predictions using the
protein sequences of Pst2p, Ycp4p and Rfs1p revealed a single,
shared, predicted domain. The reference parent, 3b6iA, is
annotated in the RCSB Protein Data Bank (http://www.rcsb.
org/pdb) as one chain of WrbA [61], a bacterial flavodoxin-like
NAD(P)H:quinone oxidoreductase from E. coli that is closely
related to mammalian Nqo1 [23,62]. NAD(P)H:quinone oxidore-
ductases catalyze the two-electron reduction of toxic quinones to
their corresponding less toxic hydroquinone, using either NADH
or NADPH as an electron donor, and with a flavin cofactor, either
FMN or FAD [63]. Direct two-electron reduction avoids redox
cycling and the resulting production of an extremely toxic and
reactive semiquinone intermediate. Concordantly, polymorphisms
of the human quinone oxidoreductase NQO1 associate with a
higher incidence of benzene-associated disease [6,64]. Protein
sequence comparisons also support Pst2p, Ycp4p and Rfs1p as
orthologs of WrbA (Figure 5B). Pst2p and Ycp4p are both 46%
identical to WrbA (Pst2p=95% coverage; Ycp4p=80% cover-
age), and Rfs1p is 37% identical to WrbA (95% coverage). Ycp4p
has previously been proposed as a structural homolog of WrbA
[60], and Pst2p, Ycp4p and Rfs1p are also all orthologs of the
previously characterized 1,4-benzoquinone oxidoreductase from
the basidiomycete fungus Phanerochaete chrysosporium [65] (Figure 5B).
Alignment of the five protein sequences shows extensive sequence
conservation, particularly in regions identified in WrbA as
important for protein function (Figure 5B), such as four key active
site residues (Phe-80, Trp-98, His-133 and Tyr-143). Although
Rfs1p has some conserved sites, there are several other residues
important for WrbA function that are conserved in Pst2p and
Ycp4 but not Rfs1p [61,62], and rfs1D has no consequences for
response to benzene metabolites (Figure S6). Thus, Rfs1p may not
function as a quinone oxidoreductase.
The only characterized yeast NAD(P)H:quinone oxidoreductase
is cytoplasmic Lot6p [66]. Lot6p is also a WrbA ortholog and is
considered to be the yeast ortholog of human NQO1. Despite
both being orthologous to WrbA, Pst2p shares only 31% identity
with Lot6p (72% coverage). Lot6p is known to reduce 1,4-BQ in
vitro [66], but lot6D was not identified as sensitive to either HQ or
BT by DSSA. We assessed the growth of lot6D following benzene
metabolite treatment and confirmed that it is not sensitive to either
Figure 3. Pathway enrichment, hierarchical clustering and network clustering analyses of TAG4 microarray data identifying
pathways and processes affected by benzene metabolite treatment. A Clustergram of KEGG pathways significantly affected by benzene
metabolite treatment. B–E Clusters (sub-networks) identified by mapping fitness data to the STRING yeast interaction data set. Clusters were
analyzed for enrichment of Gene Ontology (GO) Biological Processes within each sub-network. Cellular components required for metabolite tolerance
identified from clusters included (parentheses indicate sub-network identification number – see Tables S5 and S6): B The vacuole (5 g #8). C
Endosomes (15 g #27). D The vacuolar ATPase (15 g #39). E The actin cytoskeleton (15 g #34). In each panel, the complete cluster is visualized.
doi:10.1371/journal.pone.0024205.g003
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(Figure S6), suggesting that Lot6p can reduce 1,2-BQ in vivo;
however, this reduction may not be efficient as there was no
observed sensitivity of lot6D at a concentration close to the IC20.
To gain greater insight into the roles of these putative
oxidoreductases in benzene metabolite tolerance, we assessed the
fitness of yeast strains overexpressing both PST2 and YCP4 during
exposure (Figure 5C). Overexpression of quinone oxidoreductases
is known to modulate the toxicity of compounds; for example,
NQO1 expression influences toxicity of the chemotherapeutic
agent mitomycin C. Mitomycin C has a quinone ring that when
reduced to a hydroquinone becomes a potent alkylating agent.
Many tumor cells have endogenous overexpression of NQO1 [67],
which explains the chemotherapeutic effectiveness of the drug. In
cell culture, NQO1 overexpression also increases mitomycin C
cytotoxicity [68].
Given these data, overexpression of PST2 and YCP4 in yeast
should reverse the sensitivities seen in the corresponding deletions
following HQ treatment; both should become resistant due to
increased reduction of the more toxic 1,4-BQ back to HQ. This is
true for overexpression of PST2 (Figure 5C), but not YCP4, which
causes increased sensitivity to higher doses of HQ. A reversal of
the BT resistance measured in pst2D and ycp4D was also observed
when PST2 and YCP4 were overexpressed; both strains showed
increased sensitivity (Figure 5C). Overexpression of both PST2 and
YCP4 resulted in further increased sensitivity of both strains to
CAT treatment, for unknown reasons. This unexpected increase
could reflect strain background differences (in terms of the
enzymatic defense against CAT) between the diploid deletion
and haploid overexpression strains.
Discussion
Benzene, a ubiquitous environmental contaminant that is
widely used in industry, is an established human carcinogen. It
undergoes extensive metabolism in humans and thus the
molecular mechanisms underlying its toxicity remain elusive
despite extensive study. To gain insight into these mechanisms
we have performed genome-wide functional profiling of yeast, in
order to identify non-essential genes required for tolerance to
treatment with three phenolic benzene metabolites, hydroquinone
(HQ), catechol (CAT) and 1,2,4-benzenetriol (BT). Assessing these
metabolites individually has identified overlapping and synergistic
toxicities, consistent with previously proposed mechanisms of
carcinogenesis of benzene in which multiple metabolites act in
concert [3,4]. Comparison of the genes associated with sensitivity
to these compounds suggests a mechanistic basis for toxicity and
has identified conserved toxicity genes in humans (Table 6).
We determined that yeast cells are more resistant to HQ, CAT
and BT than human cells, based on comparison of yeast IC20
doses with treatment doses used in studies with human cells in
culture [69,70,71]. This increased resistance could be due to the
absence of peroxidase enzymes in yeast (such as MPO in humans),
which rapidly catalyze the oxidation of HQ, CAT and BT to more
toxic quinone species. We identified both distinct and overlapping
cellular processes and proteins between metabolites as important
for tolerance, including the oxidative stress response, lipid/fatty
acid transport, and the pentose phosphate pathway (Figure 6).
Data also indicate that metabolites (particularly HQ) damage
proteins, leading to both cytoskeletal and ER stress, and a
requirement for ER-associated protein degradation. The vacuole,
particularly the vacuolar ATPase, is important for tolerance.
Benzene metabolites, especially CAT, appear to disrupt intracel-
lular vesicle trafficking as an indirect result of lipid peroxidation
caused by oxidative stress and/or cytoskeletal disruption. CAT
may affect trafficking more than HQ and BT due to a bias in the
species of ROS produced upon exposure, discussed below. These
shared functional categories indicate that some molecular targets
may be common to HQ, CAT and BT.
In agreement with observations from previous studies in other
organisms [8,72,73], our results show that the primary mechanism
of toxicity of these metabolites is induction of oxidative stress; we
did not identify a requirement for the mitochondrial electron
transport chain, suggesting that the level of hydrogen peroxide
produced by HQ, CAT and BT does not significantly contribute
to oxidative toxicity. The DSSA profiles identified in our study for
HQ, CAT and BT are similar to that seen following cumene
hydroperoxide treatment, an oxidant that is structurally similar to
the phenolic metabolites of benzene [74], and requires the vacuole
and vacuolar ATPase for tolerance. The profiles of HQ and BT
from DSSA are more similar to each other than to that of CAT,
perhaps reflecting differential ROS generation due to the
difference between the para (1,4) position of the hydroxyl groups
of HQ and BT and the ortho (1,2) hydroxyl groups of CAT. HQ,
CAT and BT likely produce differing proportions of a wide range
of ROS, which require multiple oxidative stress responses for
tolerance. The lack of significant sensitivity of yeast glutathione
pathway mutants to HQ, CAT and BT reflects either a difference
in detoxification pathways between yeast and humans, or
functional redundancy between glutathione pathway enzymes in
yeast. The lack of significant sensitivity to decreased GSH levels
suggest that the yeast thioredoxin system may be more important
than the glutaredoxin system for benzene metabolite tolerance;
previous studies have suggested it also has a more prominent role
in hydrogen peroxide metabolism [75]. Based on these results, it
may be prudent to reevaluate the role of the thioredoxin pathway
in the human response to benzene metabolites.
Our data implicate the previously uncharacterized bZIP
transcription factor Yap3p as being involved in a cellular response
specific to HQ. Yap3p may respond to ER stress, as yap3D is
sensitive to tunicamycin, a compound that causes ER stress
through induction of the unfolded protein response [53]. This is
consistent with the identification of more ER stress sensitive
mutants in the HQ data compared to the CAT and BT data, and
suggests that HQ causes more extensive damage to proteins than
CAT or BT. yap3D was also identified in a similar screen as being
sensitive to arsenic (As) treatment [21], suggesting that As and HQ
(but not CAT or BT) share some cellular targets; analysis of
transcription factor binding sequences has previously shown that
Yap3p sites co-occur with those of Arr1p (Yap8p), the major
arsenic response transcription factor [76]. Tubulin may be such a
shared cellular target, as both HQ and As are able to bind to
Figure 4. Confirmation of oxidative stress mutant sensitivity by growth curve analysis. The AUC was calculated for each strain after 24 h
of exposure to the indicated doses of HQ, CAT and BT. The bars represent mean AUC as a percentage of the untreated for each strain with standard
error of three replicates. Sensitivity was determined by comparison to the wild type strain (gray bars=wild type; white bars=indicated deletion/
overexpression strain). A yap1D and skn7D are both sensitive to HQ, CAT and BT. B Overexpression of YAP1 results in resistance to HQ and CAT, but
not to BT. C yap3D is sensitive to only HQ. D Yap1-GFP is retained in the nucleus following treatment with HQ, CAT and BT, whereas Yap3-GFP is
retained in the nucleus only following treatment with HQ. Cells were treated with the IC20 dose of each metabolite for 30 min. Scale bar=2 mm. E
Overexpression of YAP3 does not affect tolerance of HQ, CAT or BT.
doi:10.1371/journal.pone.0024205.g004
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exposure to the indicated doses of HQ, CAT and BT. The bars represent mean AUC as a percentage of the untreated for each strain with standard
error of three replicates. Sensitivity was determined by comparison to the wild-type strain (gray bars=wild type; white bars=indicated deletion/
overexpression strain). A pst2D and ycp4D are both sensitive to HQ, unaffected by CAT, and resistant to BT. B Protein sequence alignment (ClustalW2)
of known and putative quinone oxidoreductases. Identical amino acids in at least 4/5 ORFs analyzed are boxed. Residues thought important for WrbA
function are indicated by arrowheads. C Overexpression of PST2 results in resistance to HQ, and sensitivity to CAT and BT. Overexpression of YCP4
results in sensitivity to HQ, CAT and BT.
doi:10.1371/journal.pone.0024205.g005
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response to cytoskeletal stress, though our hypothesis is compli-
cated by the fact that BT also inhibits microtubule polymerization
[56] without yap3D cells being sensitive to it. Overexpression of
Candida albicans YAP3 (FCR3)i nS. cerevisiae results in increased
transcription of PDR5, an ABC transporter that confers resistance
to a range of xenobiotic compounds [77], and Yap3p also interacts
with Pdr5p [78]. pdr5D was not identified as significantly sensitive
to HQ in this study (though it is sensitive to CAT) and is also not
sensitive to As [21], indicating that although PDR5 is a Yap3p
target, it is not involved in the cellular response to HQ or As.
High-throughput studies of the transcriptional targets of the total
complement of yeast transcription factors are currently being
undertaken by several groups [79], and these data will soon
elucidate Yap3p targets and provide insight into the Yap3p stress
response.
Several other processes important for benzene metabolite
tolerance such as the vacuole, iron homeostasis, and lipid
peroxidation, were likely identified due to the induction of
oxidative stress by these compounds. Loss of the V-ATPase results
Table 6. Selected yeast genes required for benzene metabolite tolerance and their orthologous human genes.
Yeast gene
a Human gene ortholog Human protein
ALF1 TBCB Tubulin-folding cofactor B
ARP1 ACTR1B Beta-centractin
CUP5 ATP6V0C V-type proton ATPase 16kDa proteolipid subunit
DRS2 ATP8B1 Probable phospholipid-transporting ATPase 1C
FRE8 DUOX2 Dual oxidase 2
HYR1 GPX3 Glutathione peroxidase 3
HRD1 SYVN1 E3 ubiquitin-protein ligase synoviolin
ISC1 SMPD2 Sphingomyelin phosphodiesterase 2
MRS4 SLC25A37 Mitoferrin-1
NCR1 NPC1 Niemann-Pick C1 protein
NFU1 NFU1 NFU1 iron-sulfur cluster scaffold homolog, mitochondrial





VMA5 ATP6V1C1 V-type proton ATPase subunit C 1
aDeletion of any of these genes increased the sensitivity of the mutant strain to HQ and/or CAT and/or BT (listed in alphabetical order).
doi:10.1371/journal.pone.0024205.t006
Figure 6. Proteins identified as being required for tolerance to benzene metabolites.
doi:10.1371/journal.pone.0024205.g006
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oxidative stress; previous data show that vacuolar function is
required for oxidative stress resistance [74]. The requirement of
the V-ATPase may also be due to a need to maintain soluble (i.e.
bioavailable) iron in the vacuole. The known decrease in available
cellular iron caused through chelation by benzene metabolites [51]
is potentiated by a disrupted V-ATPase [49,50], leading to
extremely low iron levels. HQ, CAT and BT can also cause iron
deficiency through the disruption of iron-sulfur (Fe-S) clusters by
ROS. Fe-S clusters are vital reactive centers of a large number of
proteins and are vulnerable to attack and disruption by ROS. Loss
of Fe
2+ from Fe-S clusters can lead to further ROS production
through Fenton chemistry [81], resulting in amplified disruption;
increased synthesis and assembly of new Fe-S clusters then
depletes available iron. Evidence to support the disruption of Fe-S
clusters by benzene metabolites comes from the identification by
DSSA of nfu1D (HQ). Nfu1p is a scaffold protein required for
correct assembly of Fe-S clusters in the mitochondria [82].
Additionally, MRS4 (CAT, BT) encodes a mitochondrial iron
transporter required for efficient mobilization of iron into the
mitochondria, and is known to be sensitive to low iron [47]; under
conditions requiring the increased synthesis of Fe-S clusters, mrs4D
cells are unable to transport sufficient iron into mitochondria. The
identification of sulfur metabolism (map00920) by KEGG
pathway analysis supports a requirement for increased Fe-S
synthesis in response to HQ, CAT and BT treatment.
We identified Pst2p and Ycp4p as putative mitochondrial
NAD(P)H:quinone oxidoreductases that are capable of reducing
para (1,4) quinones (such as those produced through autoxidation
of HQ and BT), but not ortho (1,2) quinones (e.g. 1,2-BQ from
autoxidation of CAT). The absence of Pst2p or Ycp4p is therefore
deleterious following HQ treatment due to increased levels of
more toxic 1,4-BQ. The resistance of both pst2D and ycp4D to BT
can be explained by the autoxidation rate of BT, which is higher
than that of HQ or CAT [83]. HQ, CAT and BT all autoxidize by
two successive one-electron oxidations, producing an extremely
reactive semiquinone intermediate; these semiquinones are the
most reactive and most toxic of the quinone species. Constant
reduction of 2-OH-1,4-BQ back to BT results in elevated levels of
transient semiquinones through repeat autoxidation of BT.
Therefore, preventing reduction of 2-OH-1,4-BQ is beneficial to
the cell as increased 2-OH-1,4-BQ is less harmful than increased
transient semiquinone levels; concordantly, strains overexpressing
PST2 and YCP4 have increased sensitivity to BT. The HQ
resistance and BT sensitivity of the PST2 overexpression strain is a
reversal of the pst2D phenotype, and provides mechanistic support
of the hypothesis that Pst2p and Ycp4p are quinone oxidoreduc-
tases. It is unclear why YCP4 overexpression causes increased
sensitivity to HQ, CAT and BT, but it could be due to unintended
general cellular consequences; the C-terminal region of Ycp4p,
which is not present in Pst2p, may aggregate at high abundance,
causing cells to become sensitized to any stressor. The lack of
sensitivity of pst2D and ycp4D to CAT (Figure 4A) can be explained
if Pst2p and Ycp4p are only able to reduce para quinones. Based
on homology to the bacterial oxidoreductase WrbA, we propose
that they function by direct two-electron reduction of quinones
with the same mechanism as human NQO1 and the characterized
cytoplasmic yeast NAD(P)H:quinone oxidoreductase Lot6p. Lot6p
is not required for tolerance to HQ or BT, despite Lot6p being
able to reduce 1,4-BQ in vitro. lot6D is, however, moderately
sensitive to CAT, indicating that Lot6p may be capable of
reducing 1,2-BQ in vivo. HQ and BT may target the mitochondria
more than CAT, as the CAT sensitivity profile has more
representation of cytoplasmic targets, such as vesicular trafficking.
We propose Pst2p and Ycp4p to be novel yeast orthologs of
NQO1 that are required for HQ tolerance.
Both homologous recombination (map03440) and non-homol-
ogous end joining (map03450) DNA repair pathways were
identified by KEGG analysis as associated with sensitivity to
benzene metabolite treatment (Figure 3A), but the absence of
strains identified by DSSA suggests genotoxicity is limited.
However, DNA damage caused by these metabolites has been
reported in many other studies and they have also been shown to
bind DNA [9]. As our study shows very strong evidence for
oxidative stress induction but only limited evidence of DNA
damage, we suggest that a significant proportion of damage
measured in other studies is an indirect effect resulting from
reactive oxygen intermediates and/or topoisomerase inhibition
[84,85,86,87,88], though we cannot rule out species differences in
damage repair.
Oxidative DNA damage occurs in several ways: Hydrogen
peroxide generated by CAT exposure increases the amount of 8-
oxodG [85], while lipid peroxidation results in the production of
malondialdehyde, which reacts with dA and dG in DNA. Lipid
damage also produces etheno adducts in DNA that rearrange to
form crosslinks between strands [89]. Yeast cells lacking the DNA
helicase Sgs1p, required for the maintenance of genomic stability,
have increased sensitivity to high doses of HQ [90], and RNAi
knockdown of WRN, the human ortholog of SGS1, increases HQ-
generated DNA damage [91].
Many of the genes identified in this study have human orthologs
(Table 6). Only two (PRDX1 and TXN) are currently associated
with HQ in the Comparative Toxicogenomics Database (http://
ctd.mdibl.org) and none are associated with CAT or BT. All could
be novel targets or modulators of benzene toxicity in humans.
Though oxidative stress appears to be the primary means through
which these metabolites exert their toxicity, many secondary
processes were also identified that could be informative in terms of
human susceptibility. The deleterious health effects caused by
benzene in humans are likely due to multiple modes of toxicity,
induced by multiple metabolites, acting synergistically [4].
Benzene is thought to cause leukemia through metabolite-
induced oxidative stress, via mitochondrial imbalance in hemato-
poietic cells [92]. The presence of phenolic benzene metabolites in
bone marrow is likely to generate more oxidative stress than
observed in yeast due to the presence of enzymes such as
myeloperoxidase, which enhances the production of benzoqui-
nones through direct oxidation [4]. There may be many as-yet
unidentified SNPs in human oxidative stress response genes that
could increase susceptibility to benzene toxicity and that should be
studied.
Materials and Methods
Yeast strains and culture
Diploid yeast deletion strains used in parallel analysis pools and
for individual strain analyses were of the BY4743 background
(MATa/MATa, his3D1/his3D1, leu2D0/leu2D0, lysD0/LYS2,
MET15/met15D0, ura3DD0/ura3D0, Invitrogen Corporation,
Carlsbad, CA). Yap1-GFP and Yap3-GFP strains were of the
haploid BY4741 background (MATa, his3D1, leu2D0, met15D0,
ura3D0, Invitrogen Corporation, Carlsbad, CA). Haploid yeast
MORF (Movable ORF-[32]) strains for protein overexpression
were of the Y258 background (MATa, pep4-3, his4-580, ura3-53,
leu2-3,112, Thermo Fisher Scientific Open Biosystems, Hunts-
ville, AL). Growth was conducted in liquid rich media (1% yeast
extract, 2% peptone, 2% dextrose, YPD) for deletion strain pool
growth and growth curve assays, and liquid synthetic complete
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raffinose as a carbon source for pre-growths of overexpression
strains for growth curve assays (detailed below). Liquid rich media
for induction of protein overexpression for growth curve assays
was liquid rich media containing both galactose and raffinose
(1% yeast extract, 2% peptone, 2% galactose, 2% raffinose,
YPGal+Raf).
Benzene metabolite exposures
Hydroquinone (HQ), catechol (CAT) and 1,2,4-benzenetriol
(BT) (Sigma-Aldrich, St Louis, MO) stock solutions were prepared
in sterile nuclease-free water (ISC BioExpress, Kaysville, UT) and
protected from light until use.
Deletion strain growth curve assays
Yeast strains were pre-grown to mid-log phase, diluted to an
optical density at 600 nm (OD600) of 0.0165, and dispensed into
different wells of a 48-well plate (non-treated polystyrene, Grenier
Bio-One, Monroe, NC). Benzene metabolite stock solutions were
added to the desired final concentrations with at least two
replicates per dose. Plates were incubated in a GENios microplate
reader (Tecan, Durham, NC) set to 30uC with intermittent
shaking. OD595 measurements were taken at 15-minute intervals
for a period of 24 hours. Raw absorbance data were averaged for
all replicates, background corrected, and plotted as a function of
time. The area under the curve (AUC) was calculated with Excel
2008 (Microsoft Corporation, Redmond, WA), as a measure of
growth, and expressed as a percentage of the control. AUCs were
compared with either one- or two-way ANOVA followed by
Dunnett or Bonferroni post-tests, respectively, using GraphPad
Prism version 5.01 (GraphPad Software, La Jolla, CA). Data for
each strain is derived from three independent biological replicates.
Overexpression strain growth curve assays
Yeast overexpression strains were pre-grown overnight to
stationary phase in SC-ura 2% dextrose, then diluted 1:100 in
SC-ura 2% raffinose and grown overnight again to alleviate
glucose repression. Cells were then diluted in YPGal+Raf to
induce protein overexpression, and grown for 5 hours to mid-log
phase. Cells were subsequently diluted to an optical density at
600 nm (OD600) of 0.0165 in YPGal+Raf, and dispensed into
different wells of a 48-well plate. Benzene metabolite treatment,
plate measurement and data processing were all carried out in the
same manner as for the deletion strain growth curve assays.
Parallel analysis of yeast deletion mutants
Pooled growth of homozygous deletion strains, genomic DNA
extraction, barcode amplification, and Affymetrix TAG4 array
hybridization were performed as previously described [21]. Raw
and processed data files are available at the Gene Expression
Omnibus (GEO) database.
Differential strain sensitivity analysis (DSSA)
Raw TAG4 array data were processed and significant strains
identified as previously described [21]. Briefly, a fitness score
(ave(log2{Y|X=treated})-ave(log2{Y|X=control}), the difference
in the mean of the log2 hybridization signal between treatment and
control) was calculated for each deletion strain, to identify those
differentially sensitive. This fitness score is an indicator of the effect
of the benzene metabolite on the growth of the deletion strain. A
negative fitness score indicates the deletion strain is sensitive to
benzene metabolite treatment, and that the gene product absent in
that strain is likely required for tolerance to that metabolite.
MIPS functional classification scoring
Data sets from DSSA were verified for enrichment of any
particular biological attribute by identifying significantly overrep-
resented MIPS (Munich Information Center for Protein Sequenc-
es) Functional Classification categories [93] by a hypergeometric
distribution using the Functional Specification resource, FunSpec
(http://funspec.med.utoronto.ca/) [94], with a p-value cutoff of
0.01.
Pathway enrichment and hierarchical clustering
Raw TAG4 array data were normalized using the Faster Cyclic
Loess Method [95] through the fastlo package in R [96], adapted
for the TAG4 chip design [97]. Normalization for each benzene
metabolite was performed separately and each normalization set
also included control chips. For the purpose of normalization,
hybridization signals of UP and DOWN barcodes of the same
deletion strain were treated as separate measurements and then
grouped following normalization.
The normalized data for each benzene metabolite was used in a
pathway enrichment method called Structurally Enhanced
Pathway Enrichment Analysis (SEPEA), [98]. The biochemical
pathways chosen were from the S. cerevisiae KEGG pathway
database [99]. SEPEA differs from other pathway enrichment
methods in that it considers the network structure of the various
pathways in the analyses – pathways where perturbed genes
(whose deletion strain hybridization signal is altered as a result of
metabolite treatment) are a close relative to each other in a graph/
network sense are assigned more significance. The gene-wise
statistic chosen to be used by SEPEA was the non-parametric
Kruskal-Wallis anova statistic [100], which compares medians of
four groups of treatments (control, 25% IC20, 50% IC20 and IC20
concentrations) with 12, 3, 3, 3 replicates in each of the groups
respectively. Several null hypotheses for SEPEA have been
previously described [98]. In this study, SEPEA_NT2 with 10ˆ5
permutations was chosen for analyses. For each pathway, the null
hypothesis tested by SEPEA_NT2 is that the growth phenotype
corresponding to deletion strains associated with each of the genes
involved in the pathway is independent of the administered dose of
the given benzene metabolite. SEPEA_NT2 was coded in Java
programming language [101].
Not all genes present in the KEGG database have associated
experimental measurements, due to the use of only the non-
essential deletion collection of strains in this study. We therefore
selected KEGG pathways with TAG4 array data for at least 60%
of their genes. This resulted in 43 pathways, whose associated
SEPEA p-values were negative log10 transformed and hierarchi-
cally clustered in Cluster 3.0 [102], using Spearman rank
correlation as a measure of distance and average linkage for
forming clustering. The resultant clustergram was viewed in
TreeView [102].
Network clustering
The manuscript (Thomas, R. et al.) describing the statistical
methodology for network clustering is in preparation. The
methodology uses an overall system-wide interaction network as
a basis for the analyses. In this analysis, the protein interaction
network from the STRING database [103] is used. Associated
with each interaction in STRING is a score (ranging from 0–1000)
for how likely it is to be a true positive. S. cerevisiae protein
interactions with a score cutoff of 700 (defined as ‘‘high-
confidence’’) were used. Approximately 4000 proteins with
150000 interactions represent this interaction network; these
proteins formed the network nodes. The degree of a node is the
number of interactions that it is involved in. The node degree
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were a relatively small number of nodes involved in a large
number of interactions. Such nodes are referred to as hub nodes.
Significant genes identified in each of the metabolite treatments
were determined by fitting gene-specific mixed effects models to
the previously described fastlo normalized data. The model takes
into account correlation between UP and DOWN barcode
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The mixed models were estimated using the nlme package in R
[104]. A Holm step-down multiple testing correction (using the
multtest package in R [105]) was applied to the p-values that were
based on Likelihood Ratio Statistic; the resulting set of genes
(deletion strains) was obtained from a 0.05 cut-off.
For the analysis across the metabolites, deletion strains sensitive
to at least one of the metabolites were selected. Data for the
different generation points (5 g and 15 g) were considered
independently.
These metabolite-specific data sets were mapped onto the
system-wide interaction network. The goal of the network
clustering analysis was to find sub-networks in this system-wide
network that are enriched with targets of different combinations of
metabolites. The significance of different clusters is based on the
overall neighborhood characteristics of the nodes of the interaction
network. For example, by random chance it is likely that a
randomly picked node is closer to a given hub node than a non-
hub node. The analyses were coded in Java programming
language [101]. Clusters (sub-networks) were visualized using
Cytoscape version 2.8.0 [106]. Enrichment analysis for identifica-
tion of significantly overrepresented Gene Ontology (GO)
Biological Processes [107] within clusters was conducted using
the R package topGO [108].
Fluorescence microscopy
Yap1-GFP and Yap3-GFP were grown to mid-log phase and
300 ml of cells were treated with the IC20 dose of HQ, CAT or BT
(see Table 1) for 30 minutes. 3 ml of cells were transferred to glass
slides following treatment, and microscopy was performed on a
Deltavision Spectris DV4 deconvolution microscope (Applied
Precision Instruments, Issaquah, WA). Images were not processed.
Domain prediction, protein identity calculation and
sequence alignment
Domain predictions for Pst2p, Ycp4p and Rfs1p were generated
using the Ginzu process of the Robetta full-chain protein structure
prediction server (http://robetta.bakerlab.org) [109]. Sequence
identity between proteins was calculated with BLASTp (http://
blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins), using default
parameters. Sequences were aligned with ClustalW2 (http://www.
ebi.ac.uk/Tools/clustalw2/index.html), using default parameters.
Supporting Information
Figure S1 Dose determination of hydroquinone (HQ)
for parallel analysis studies. Growth curve assay for BY4743
wild type treated with increasing concentrations of HQ in YPD
media. Measurements of the optical density at 595 nm were taken
at 15-minute intervals, with each point in the curve representing
the average of three replicate measurements in the microplate.
Standard error was omitted from the graph for clarity. Total cell
growth in 24 h was determined by calculating the area under the
curve (AUC) for each of the growth curves. The selected exposures
concentrations were 1,2 and 4 mM HQ.
(PDF)
Figure S2 Dose determination of catechol (CAT) for
parallel analysis studies. Growth curve assay for BY4743 wild
type treated with increasing concentrations of CAT in YPD
media. Measurements of the optical density at 595 nm were taken
at 15-minute intervals, with each point in the curve representing
the average of three replicate measurements in the microplate.
Standard error was omitted from the graph for clarity. Total cell
growth in 24 h was determined by calculating the area under the
curve (AUC) for each of the growth curves. The selected exposures
concentrations were 0.55,1.1 and 2.2 mM CAT.
(PDF)
Figure S3 Dose determination of 1,2,4-benzenetriol
(BT) for parallel analysis studies. Growth curve assay for
BY4743 wild type treated with increasing concentrations of BT in
YPD media. Measurements of the optical density at 595 nm were
taken at 15-minute intervals, with each point in the curve
representing the average of three replicate measurements in the
microplate. Standard error was omitted from the graph for clarity.
Total cell growth in 24 h was determined by calculating the area
under the curve (AUC) for each of the growth curves. The selected
exposures concentrations were 87.5,175 and 350 mM BT.
(PDF)
Figure S4 Growth curve analysis of glutathione pathway
mutants. The AUC was calculated for each strain after 24 h of
exposure to the indicated doses of HQ, CAT and BT. The bars
represent mean AUC as a percentage of the untreated for each
strain with standard error of three replicates. Sensitivity was
determined by comparison to the wild type strain (gray bars=wild
type; white bars=indicated deletion strain). There is no significant
requirement for the glutaredoxin pathway for tolerance of any of
the metabolites tested at the IC20 dose, although glr1D is
moderately sensitive to HQ, and gsh1D shows some sensitivity to
both CAT and BT.
(PDF)
Figure S5 Growth curve analysis of iron homeostasis
mutants. The AUC was calculated for each strain after 24 h of
exposure to the indicated doses of HQ, CAT and BT. The bars
represent mean AUC as a percentage of the untreated for each
strain with standard error of three replicates. Sensitivity was
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type; white bars=indicated deletion strain). Both aft1D and cup5D
are extremely sensitive to HQ, CAT and BT. The negative AUC
values for cup5D treated with BT are due to the slow growth (and
so low AUC values) of cup5D combined with the absorbance at
595 nm of a BT-derived compound. It was not possible to assess
aft1D when treated with BT, due to insufficient growth of an
untreated control to use for normalization. However, no growth of
aft1D was ever seen following BT treatment at any dose.
(PDF)
Figure S6 Growth curve analysis of rfs1D and lot6D. The
AUC was calculated for each strain after 24 h of exposure to the
indicated doses of HQ, CAT and BT. The bars represent mean
AUC as a percentage of the untreated for each strain with standard
error of three replicates. Sensitivity was determined by comparison
to the wild type strain (gray bars=wild type; white bars=indicated
deletion strain). Deletion of RFS1 has no effect on HQ, CAT or BT
tolerance. The sensitivity of lot6D to CAT suggests that Lot6p may
reduce the quinone form of CAT (1,2-BT) in vivo.
(PDF)
Table S1 Complete list of yeast genes (n=478) identi-
fied by DSSA after treatment with hydroquinone (HQ),
ranked by the number of hits in 6 treatments. Yeast pools
were exposed to 3 different concentrations of hydroquinone for
two generation-points, for a total of 6 treatments. The yeast
ORFs/genes correspond to deletion strains that exhibited a
significant change in growth in at least one treatment with
hydroquinone (q,0.05). Numeric values are fitness scores (log2
ratios) calculated only for significant genes in each individual
treatment. Empty cells indicate that the gene was not significant in
that particular treatment.
(DOC)
Table S2 Complete list of yeast genes (n=528) identi-
fied by DSSA after treatment with catechol (CAT),
ranked by the number of hits in 6 treatments. Yeast pools
were exposed to 3 different concentrations of catechol for two
generation-points, for a total of 6 treatments. The yeast ORFs/
genes correspond to deletion strains that exhibited a significant
change in growth in at least one treatment with catechol (q,0.05).
Numeric values are fitness scores (log2 ratios) calculated only for
significant genes in each individual treatment. Empty cells indicate
that the gene was not significant in that particular treatment.
(DOC)
Table S3 Complete list of yeast genes (n=604) identi-
fied by DSSA after treatment with 1,2,4-benzenetriol
(BT), ranked by the number of hits in 6 treatments. Yeast
pools were exposed to 3 different concentrations of 1,2,4-
benzenetriol for two generation-points, for a total of 6 treatments.
The yeast ORFs/genes correspond to deletion strains that
exhibited a significant change in growth in at least one treatment
with 1,2,4-benzenetriol (q,0.05). Numeric values are fitness scores
(log2 ratios) calculated only for significant genes in each individual
treatment. Empty cells indicate that the gene was not significant in
that particular treatment.
(DOC)
Table S4 Complete results of KEGG pathway enrich-
ment analysis. This study provided data for ,900 of the ,2000
genes represented in the 99 annotated KEGG pathways for S.
cerevisiae. Highlighted in yellow are the 43 KEGG pathways for
which at least 60% of genes annotated to that pathway are present
in the PDA screen data - these pathways are clustered in Figure 3A.
(XLS)
Table S5 Complete results of network clustering anal-
ysis at 5 generations. 19 sub-networks (clusters) were identified
at 5 g. The four most significantly enriched GO Biological
Processes are shown for each network.
(XLS)
Table S6 Complete results of network clustering anal-
ysis at 15 generations. 41 sub-networks (clusters) were
identified at 15 g. The four most significantly enriched GO
Biological Processes are shown for each network.
(XLS)
Acknowledgments
We thank Dr. William J. Jo for helpful discussions, Dr. Abby Leeder for
technical assistance with fluorescence microscopy, and Mr. Barry Ko for
technical assistance. MN is a postdoctoral trainee in the Superfund
Research Program at the University of California, Berkeley.
Author Contributions
Conceived and designed the experiments: MN LZ MTS CDV. Performed
the experiments: MN VJT. Analyzed the data: MN RT AL IG.
Contributed reagents/materials/analysis tools: AH LZ MTS CDV. Wrote
the paper: MN RT IG AH LZ MTS CDV.
References
1. Smith MT (2010) Advances in Understanding Benzene Health Effects and
Susceptibility. Annual review of public health 31: 133–148.
2. Snyder R, Hedli C (1996) An overview of benzene metabolism. Environ Health
Perspect 104 Suppl 6: 1165–1171.
3. Eastmond DA, Smith MT, Irons RD (1987) An interaction of benzene
metabolites reproduces the myelotoxicity observed with benzene exposure.
Toxicology and applied pharmacology 91: 85–95.
4. Smith M (1996) The mechanism of benzene-induced leukemia: a hypothesis
and speculations on the causes of leukemia. Environ Health Perspect 104 Suppl
6: 1219–1225.
5. Ross D (2005) Functions and distribution of NQO1 in human bone marrow:
potential clues to benzene toxicity. Chem Biol Interact 153-154: 137–146.
6. Lan Q (2004) Hematotoxicity in Workers Exposed to Low Levels of Benzene.
Science 306: 1774–1776.
7. Gill DP, Ahmed AE (1981) Covalent binding of [14C]benzene to cellular
organelles and bone marrow nucleic acids. Biochem Pharmacol 30: 1127–1131.
8. Shen Y, Shen HM, Shi CY, Ong CN (1996) Benzene metabolites enhance
reactive oxygen species generation in HL60 human leukemia cells. Hum Exp
Toxicol 15: 422–427.
9. Gaskell M, McLuckie KIE, Farmer PB (2005) Genotoxicity of the benzene
metabolites para-benzoquinone and hydroquinone. Chem Biol Interact 153-
154: 267–270.
10. Singh MP, Reddy MMK, Mathur N, Saxena DK, Chowdhuri DK (2009)
Induction of hsp70, hsp60, hsp83 and hsp26 and oxidative stress markers in
benzene, toluene and xylene exposed Drosophila melanogaster: role of ROS
generation. Toxicology and applied pharmacology 235: 226–243.
11. Jemnitz K, Veres Z, Torok G, Toth E, Vereczkey L (2004) Comparative study
in the Ames test of benzo[a]pyrene and 2-aminoanthracene metabolic
activation using rat hepatic S9 and hepatocytes following in vivo or in vitro
induction. Mutagenesis 19: 245–250.
12. Hirakawa K, Oikawa S, Hiraku Y, Hirosawa I, Kawanishi S (2002) Catechol
and hydroquinone have different redox properties responsible for their
differential DNA-damaging ability. Chem Res Toxicol 15: 76–82.
13. Gaskell M, McLuckie K, Farmer P (2005) Comparison of the repair of DNA
damage induced by the benzene metabolites hydroquinone and p-benzoqui-
none: a role for hydroquinone in benzene genotoxicity. Carcinogenesis 26:
673–680.
14. Brennan RJ, Schiestl RH (1998) Free radicals generated in yeast by the
Salmonella test-negative carcinogens benzene, urethane, thiourea and
auramine O. Mutat Res 403: 65–73.
15. Snyder R (2007) Benzene’s toxicity: a consolidated short review of human and
animal studies by HA Khan. Hum Exp Toxicol 26: 687–696.
16. Giaever G, Chu AM, Ni L, Connelly C, Riles L, et al. (2002) Functional
profiling of the Saccharomyces cerevisiae genome. Nature 418: 387–391.
Functional Profiling of Benzene Toxicity
PLoS ONE | www.plosone.org 17 August 2011 | Volume 6 | Issue 8 | e2420517. Birrell GW, Brown JA, Wu HI, Giaever G, Chu AM, et al. (2002)
Transcriptional response of Saccharomyces cerevisiae to DNA-damaging
agents does not identify the genes that protect against these agents. Proc Natl
Acad Sci USA 99: 8778–8783.
18. Holland S, Lodwig E, Sideri T, Reader T, Clarke I, et al. (2007) Application of
the comprehensive set of heterozygous yeast deletion mutants to elucidate the
molecular basis of cellular chromium toxicity. Genome Biol 8: R268.
19. Hoon S, St Onge R, Giaever G, Nislow C (2008) Yeast chemical genomics and
drug discovery: an update. Trends in Pharmacological Sciences 29: 499–504.
20. Jo WJ, Loguinov A, Chang M, Wintz H, Nislow C, et al. (2008) Identification
of genes involved in the toxic response of Saccharomyces cerevisiae against iron
and copper overload by parallel analysis of deletion mutants. Toxicol Sci 101:
140–151.
21. Jo W, Loguinov A, Wintz H, Chang M, Smith A, et al. (2009) Comparative
Functional Genomic Analysis Identifies Distinct and Overlapping Sets of Genes
Required for Resistance to Monomethylarsonous Acid (MMAIII) and Arsenite
(AsIII) in Yeast. Toxicol Sci 111: 424–436.
22. Jo W, Ren X, Chu F, Aleshin M, Wintz H, et al. (2009) Acetylated H4K16 by
MYST1 protects UROtsa cells from arsenic toxicity and is decreased following
chronic arsenic exposure. Toxicology and Applied Pharmacology 241:
294–302.
23. Patridge EV, Ferry JG (2006) WrbA from Escherichia coli and Archaeoglobus
fulgidus is an NAD(P)H:quinone oxidoreductase. J Bacteriol 188: 3498–3506.
24. Varela E, Tien M (2003) Effect of pH and oxalate on hydroquinone-derived
hydroxyl radical formation during brown rot wood degradation. Appl Environ
Microbiol 69: 6025–6031.
25. Lee J, Godon C, Lagniel G, Spector D, Garin J, et al. (1999) Yap1 and Skn7
control two specialized oxidative stress response regulons in yeast. J Biol Chem
274: 16040–16046.
26. Delaunay A, Pflieger D, Barrault MB, Vinh J, Toledano MB (2002) A thiol
peroxidase is an H2O2 receptor and redox-transducer in gene activation. Cell
111: 471–481.
27. Okazaki S, Naganuma A, Kuge S (2005) Peroxiredoxin-mediated redox
regulation of the nuclear localization of Yap1, a transcription factor in budding
yeast. Antioxid Redox Signal 7: 327–334.
28. Veal EA, Ross SJ, Malakasi P, Peacock E, Morgan BA (2003) Ybp1 is required
for the hydrogen peroxide-induced oxidation of the Yap1 transcription factor.
J Biol Chem 278: 30896–30904.
29. Menezes RA, Amaral C, Batista-Nascimento L, Santos C, Ferreira RB, et al.
(2008) Contribution of Yap1 towards Saccharomyces cerevisiae adaptation to
arsenic-mediated oxidative stress. Biochem J 414: 301–311.
30. Akada R, Shimizu Y, Matsushita Y, Kawahata M, Hoshida H, et al. (2001) Use
of aYAP1 overexpression cassette conferring specific resistance to cerulenin and
cycloheximide as an efficient selectable marker in the yeastSaccharomyces
cerevisiae. Yeast 19: 17–28.
31. Bossier P, Fernandes L, Rocha D, Rodrigues-Pousada C (1993) Overexpression
of YAP2, coding for a new yAP protein, and YAP1 in Saccharomyces
cerevisiae alleviates growth inhibition caused by 1,10-phenanthroline. J Biol
Chem 268: 23640–23645.
32. Gelperin DM, White MA, Wilkinson ML, Kon Y, Kung LA, et al. (2005)
Biochemical and genetic analysis of the yeast proteome with a movable ORF
collection. Genes & Development 19: 2816–2826.
33. Fernandes L, Rodrigues-Pousada C, Struhl K (1997) Yap, a novel family of
eight bZIP proteins in Saccharomyces cerevisiae with distinct biological
functions. Mol Cell Biol 17: 6982–6993.
34. Wysocki R, Fortier P-K, Maciaszczyk E, Thorsen M, Leduc A, et al. (2004)
Transcriptional activation of metalloid tolerance genes in Saccharomyces
cerevisiae requires the AP-1-like proteins Yap1p and Yap8p. Mol Biol Cell 15:
2049–2060.
35. Gulshan K, Rovinsky SA, Coleman ST, Moye-Rowley WS (2005) Oxidant-
specific folding of Yap1p regulates both transcriptional activation and nuclear
localization. J Biol Chem 280: 40524–40533.
36. Vignols F, Bre ´he ´lin C, Surdin-Kerjan Y, Thomas D, Meyer Y (2005) A yeast
two-hybrid knockout strain to explore thioredoxin-interacting proteins in vivo.
Proc Natl Acad Sci USA 102: 16729–16734.
37. Wong C-M, Siu K-L, Jin D-Y (2004) Peroxiredoxin-null yeast cells are
hypersensitive to oxidative stress and are genomically unstable. J Biol Chem
279: 23207–23213.
38. Biteau B, Labarre J, Toledano MB (2003) ATP-dependent reduction of
cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425: 980–984.
39. Cha M-K, Hong S-K, Oh Y-M, Kim I-H (2003) The protein interaction of
Saccharomyces cerevisiae cytoplasmic thiol peroxidase II with SFH2p and its
in vivo function. J Biol Chem 278: 34952–34958.
40. Dougherty D, Garte S, Barchowsky A, Zmuda J, Taioli E (2008) NQO1,
MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of
benzene exposure--a literature review. Toxicol Lett 182: 7–17.
41. Kumar M, Chauhan LKS, Paul BN, Agarwal SK, Goel SK (2009) GSTM1,
GSTT1, and GSTP1 polymorphism in north Indian population and its
influence on the hydroquinone-induced in vitro genotoxicity. Toxicology
Mechanisms and Methods 19: 59–65.
42. Gardner RG, Swarbrick GM, Bays NW, Cronin SR, Wilhovsky S, et al. (2000)
Endoplasmic reticulum degradation requires lumen to cytosol signaling.
Transmembrane control of Hrd1p by Hrd3p. J Cell Biol 151: 69–82.
43. Chen Y, Feldman DE, Deng C, Brown JA, De Giacomo AF, et al. (2005)
Identification of mitogen-activated protein kinase signaling pathways that
confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae.
Mol Cancer Res 3: 669–677.
44. Sul D, Shim I, Im H, Won N, Kim H, et al. (2005) Benzene increases the ratio
of arachidonic acids to docosahexaenoic acids and inhibits the de novo
synthesis of ceramide in the rat liver. J Appl Toxicol 25: 74–81.
45. Girao H, Geli M-I, Idrissi F-Z (2008) Actin in the endocytic pathway: from
yeast to mammals. FEBS Lett 582: 2112–2119.
46. Yamaguchi-Iwai Y, Dancis A, Klausner R (1995) AFT1: a mediator of iron
regulated transcriptional control in Saccharomyces cerevisiae. EMBO J 14:
1231–1239.
47. De Freitas J, Kim J, Poynton H, Su T, Wintz H, et al. (2004) Exploratory and
confirmatory gene expression profiling of mac1Delta. J Biol Chem 279:
4450–4458.
48. Eide DJ, Bridgham JT, Zhao Z, Mattoon JR (1993) The vacuolar H(+)-ATPase
of Saccharomyces cerevisiae is required for efficient copper detoxification,
mitochondrial function, and iron metabolism. Mol Gen Genet 241: 447–456.
49. Szczypka MS, Zhu Z, Silar P, Thiele DJ (1997) Saccharomyces cerevisiae
mutants altered in vacuole function are defective in copper detoxification and
iron-responsive gene transcription. Yeast 13: 1423–1435.
50. Kaplan CD, Kaplan J (2009) Iron acquisition and transcriptional regulation.
Chem Rev 109: 4536–4552.
51. Singh V, Ahmad S, Rao G (1994) Prooxidant and antioxidant properties of
iron-hydroquinone and iron-1,2,4-benzenetriol complex. Implications for
benzene toxicity. Toxicology 89: 25–33.
52. Sa ´nchez P, Ga ´lvez N, Colacio E, Min ˜ones E, Domı ´nguez-Vera JM (2005)
Catechol releases iron(III) from ferritin by direct chelation without iron(II)
production. Dalton Trans. pp 811–813.
53. Tan S-X, Teo M, Lam YT, Dawes IW, Perrone GG (2009) Cu, Zn superoxide
dismutase and NADP(H) homeostasis are required for tolerance of endoplasmic
reticulum stress in Saccharomyces cerevisiae. Mol Biol Cell 20: 1493–1508.
54. Irons RD, Neptun DA (1980) Effects of the principal hydroxy-metabolites of
benzene on microtubule polymerization. Arch Toxicol 45: 297–305.
55. Pfeiffer E, Metzler M (1996) Interaction of p-benzoquinone and p-
biphenoquinone with microtubule proteins in vitro. Chem Biol Interact 102:
37–53.
56. Zhang L, Robertson ML, Kolachana P, Davison AJ, Smith MT (1993)
Benzene metabolite, 1,2,4-benzenetriol, induces micronuclei and oxidative
DNA damage in human lymphocytes and HL60 cells. Environ Mol Mutagen
21: 339–348.
57. Shiga T, Suzuki H, Yamamoto A, Yamamoto H, Yamamoto K (2010)
Hydroquinone, a Benzene Metabolite, Induces Hog1-dependent Stress
Response Signaling and Causes Aneuploidy in Saccharomyces cerevisiae.
JRR 51: 405–415.
58. Garg TK, Chang JY (2003) Oxidative stress causes ERK phosphorylation and
cell death in cultured retinal pigment epithelium: prevention of cell death by
AG126 and 15-deoxy-delta 12, 14-PGJ2. BMC Ophthalmol 3: 5.
59. Pons M, Cousins SW, Csaky KG, Striker G, Marin-Castan ˜o ME (2010)
Cigarette Smoke-Related Hydroquinone Induces Filamentous Actin Reorga-
nization and Heat Shock Protein 27 Phosphorylation through p38 and
Extracellular Signal-Regulated Kinase 1/2 in Retinal Pigment Epithelium.
Implications for Age-Related Macular Degeneration. The American journal of
pathology 177: 1198–1213.
60. Grandori R, Carey J (1994) Six new candidate members of the alpha/beta
twisted open-sheet family detected by sequence similarity to flavodoxin. Protein
Sci 3: 2185–2193.
61. Andrade SLA, Patridge EV, Ferry JG, Einsle O (2007) Crystal structure of the
NADH:quinone oxidoreductase WrbA from Escherichia coli. J Bacteriol 189:
9101–9107.
62. Carey J, Brynda J, Wolfova ´ J, Grandori R, Gustavsson T, et al. (2007) WrbA
bridges bacterial flavodoxins and eukaryotic NAD(P)H:quinone oxidoreduc-
tases. Protein Sci 16: 2301–2305.
63. Deller S, Macheroux P, Sollner S (2008) Flavin-dependent quinone reductases.
Cell Mol Life Sci 65: 141–160.
64. Wan J, Shi J, Hui L, Wu D, Jin X, et al. (2002) Association of genetic
polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with
benzene poisoning. Environ Health Perspect 110: 1213–1218.
65. Akileswaran L, Brock BJ, Cereghino JL, Gold MH (1999) 1,4-benzoquinone
reductase from Phanerochaete chrysosporium: cDNA cloning and regulation of
expression. Appl Environ Microbiol 65: 415–421.
66. Sollner S, Nebauer R, Ehammer H, Prem A, Deller S, et al. (2007) Lot6p from
Saccharomyces cerevisiae is a FMN-dependent reductase with a potential role
in quinone detoxification. FEBS J 274: 1328–1339.
67. Zappa F, Ward T, Butler J, Pedrinis E, McGown A (2001) Overexpression of
NAD(P)H:quinone oxidoreductase 1 in human reproductive system.
J Histochem Cytochem 49: 1187–1188.
68. Seow HA, Penketh PG, Belcourt MF, Tomasz M, Rockwell S, et al. (2004)
Nuclear overexpression of NAD(P)H:quinone oxidoreductase 1 in Chinese
hamster ovary cells increases the cytotoxicity of mitomycin C under aerobic
and hypoxic conditions. J Biol Chem 279: 31606–31612.
69. Gopalakrishna R, Chen ZH, Gundimeda U (1994) Tobacco smoke tumor
promoters, catechol and hydroquinone, induce oxidative regulation of protein
Functional Profiling of Benzene Toxicity
PLoS ONE | www.plosone.org 18 August 2011 | Volume 6 | Issue 8 | e24205kinase C and influence invasion and metastasis of lung carcinoma cells. Proc
Natl Acad Sci USA 91: 12233–12237.
70. Gillis B, Gavin IM, Arbieva Z, King ST, Jayaraman S, et al. (2007)
Identification of human cell responses to benzene and benzene metabolites.
Genomics 90: 324–333.
71. Ren X, Lim S, Smith MT, Zhang L (2009) Werner syndrome protein, WRN,
protects cells from DNA damage induced by the benzene metabolite
hydroquinone. Toxicol Sci 107: 367–375.
72. Barreto G, Madureira D, Capani F, Aon-Bertolino L, Saraceno E, et al. (2009)
The role of catechols and free radicals in benzene toxicity: An oxidative DNA
damage pathway. Environ Mol Mutagen 50: 771–780.
73. Badham HJ, Winn LM (2010) In Utero Exposure to Benzene Disrupts Fetal
Hematopoietic Progenitor Cell Growth via Reactive Oxygen Species. Toxicol
Sci 113: 207–215.
74. Thorpe GW, Fong CS, Alic N, Higgins VJ, Dawes IW (2004) Cells have
distinct mechanisms to maintain protection against different reactive oxygen
species: oxidative-stress-response genes. Proc Natl Acad Sci USA 101:
6564–6569.
75. Toledano MB, Kumar C, Le Moan N, Spector D, Tacnet F (2007) The system
biology of thiol redox system in Escherichia coli and yeast: differential functions
in oxidative stress, iron metabolism and DNA synthesis. FEBS Lett 581:
3598–3607.
76. Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, et al. (2004)
Transcriptional regulatory code of a eukaryotic genome. Nature 431: 99–104.
77. Yang X, Talibi D, Weber S, Poisson G, Raymond M (2001) Functional
isolation of the Candida albicans FCR3 gene encoding a bZip transcription
factor homologous to Saccharomyces cerevisiae Yap3p. Yeast 18: 1217–1225.
78. Subba Rao G, Bachhawat AK, Gupta CM (2002) Two-hybrid-based analysis
of protein-protein interactions of the yeast multidrug resistance protein, Pdr5p.
Funct Integr Genomics 1: 357–366.
79. Venters BJ, Wachi S, Mavrich TN, Andersen BE, Jena P, et al. (2011) A
comprehensive genomic binding map of gene and chromatin regulatory
proteins in Saccharomyces. Molecular Cell 41: 480–492.
80. Milgrom E, Diab H, Middleton F, Kane PM (2007) Loss of vacuolar proton-
translocating ATPase activity in yeast results in chronic oxidative stress. J Biol
Chem 282: 7125–7136.
81. Py B, Barras F (2010) Building Fe-S proteins: bacterial strategies. Nat Rev
Micro 8: 436–446.
82. Schilke B, Voisine C, Beinert H, Craig E (1999) Evidence for a conserved
system for iron metabolism in the mitochondria of Saccharomyces cerevisiae.
Proc Natl Acad Sci USA 96: 10206–10211.
83. Zhang L, Smith MT, Bandy B, Tamaki SJ, Davison AJ (1994) Role of
quinones, active oxygen species and metals in the genotoxicity of 1,2,4-
benzenetriol, a metabolite of benzene In: Nohl H, Esterbauer H, Rice-Evans C,
eds. Free Radicals in the Environment, Medicine and Toxicology. London:
Richelieu Press. pp 521–562.
84. Lindsey R, Bender R, Osheroff N (2005) Stimulation of topoisomerase II-
mediated DNA cleavage by benzene metabolites. Chem Biol Interact 153-154:
197–205.
85. Oikawa S, Hirosawa I, Hirakawa K, Kawanishi S (2001) Site specificity and
mechanism of oxidative DNA damage induced by carcinogenic catechol.
Carcinogenesis 22: 1239–1245.
86. Eastmond DA, Mondrala ST, Hasegawa L (2005) Topoisomerase II inhibition
by myeloperoxidase-activated hydroquinone: a potential mechanism underly-
ing the genotoxic and carcinogenic effects of benzene. Chem Biol Interact 153-
154: 207–216.
87. Buthbumrung N, Mahidol C, Navasumrit P, Promvijit J, Hunsonti P, et al.
(2008) Oxidative DNA damage and influence of genetic polymorphisms among
urban and rural schoolchildren exposed to benzene. Chem Biol Interact 172:
185–194.
88. Winn L (2003) Homologous recombination initiated by benzene metabolites: a
potential role of oxidative stress. Toxicol Sci 72: 143–149.
89. Delaney JC, Smeester L, Wong C, Frick LE, Taghizadeh K, et al. (2005) AlkB
reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo. Nat
Struct Mol Biol 12: 855–860.
90. Lan Q, Zhang L, Shen M, Jo WJ, Vermeulen R, et al. (2009) Large-scale
evaluation of candidate genes identifies associations between DNA repair and
genomic maintenance and development of benzene hematotoxicity. Carcino-
genesis 30: 50–58.
91. Galvan N, Lim S, Zmugg S, Smith M, Zhang L (2008) Depletion of WRN
enhances DNA damage in HeLa cells exposed to the benzene metabolite,
hydroquinone. Mutat Res 649: 54–61.
92. Lyu BN, Ismailov SB, Ismailov B, Lyu MB (2008) Mitochondrial concept of
leukemogenesis: key role of oxygen-peroxide effects. Theor Biol Med Model 5:
23.
93. Mewes HW, Frishman D, Gu ¨ldener U, Mannhaupt G, Mayer K, et al. (2002)
MIPS: a database for genomes and protein sequences. Nucleic Acids Res 30:
31–34.
94. Robinson M, Grigull J, Mohammad N, Hughes T (2002) FunSpec: a web-
based cluster interpreter for yeast. BMC Bioinformatics 3: 35.
95. Ballman KV, Grill DE, Oberg AL, Therneau TM (2004) Faster cyclic loess:
normalizing RNA arrays via linear models. Bioinformatics 20: 2778–2786.
96. Team R (2008) R: A language and environment for statistical computing. R
Foundation for Statistical Computing Vienna Austria.
97. Gerlovina I (2010) Bioinformatic Approaches to Parallel Deletion Analysis in
Yeast: An Example Studying Environmental Exposure. Unpublished Master’s
Thesis, University of California, Berkeley.
98. Thomas R, Gohlke JM, Stopper GF, Parham FM, Portier CJ (2009) Choosing
the right path: enhancement of biologically relevant sets of genes or proteins
using pathway structure. Genome Biol 10: R44.
99. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, et al. (2008) KEGG
for linking genomes to life and the environment. Nucleic Acids Research 36:
D480–484.
100. Kruskal WH, Wallis WA (1952) Use of ranks in one-criterion variance analysis.
Journal of the American statistical Association 47: 583–621.
101. Gosling J, Joy B, Steele G, Bracha G (2000) The Java language specification
Second Edition. Addison-Wesley Professional.
102. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and
display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:
14863–14868.
103. Von Mering C, Jensen LJ, Kuhn M, Chaffron S, Doerks T, et al. (2007)
STRING 7--recent developments in the integration and prediction of protein
interactions. Nucleic Acids Research 35: D358–362.
104. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Core Team (2009) nlme: Linear
and Nonlinear Mixed Effects Models. R package version 31-96.
105. Pollard KS, Gilbert HN, Ge Y, Taylor S, Dudoit S (2010) multtest:
Resampling-based multiple hypothesis testing. R package version 2514.
106. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape:
a software environment for integrated models of biomolecular interaction
networks. Genome Res 13: 2498–2504.
107. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene
ontology: tool for the unification of biology. The Gene Ontology Consortium.
Nat Genet 25: 25–29.
108. Alexa A, Rahnenfuhrer J (2009) topGO: Enrichment analysis for Gene
Ontology. R package version 1162.
109. Chivian D, Kim DE, Malmstro ¨m L, Bradley P, Robertson T, et al. (2003)
Automated prediction of CASP-5 structures using the Robetta server. Proteins
53 Suppl 6: 524–533.
Functional Profiling of Benzene Toxicity
PLoS ONE | www.plosone.org 19 August 2011 | Volume 6 | Issue 8 | e24205